Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phthalocyanine-based photosensitizers designed by Nihon U. scientists

Nov. 24, 2003

FTY-720 exerts selective antitumor effects on hepatoma cell lines

Nov. 24, 2003

Good tolerability profile for OSI-461 in advanced cancer patients

Nov. 24, 2003

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Oncolytics Biotech

Nov. 24, 2003

Small-molecule HDAC inhibitor JNJ-16241199, a potent, orally active antitumor agent

Nov. 21, 2003

Strong antitumor effects demonstrated for humanized anti-TF monoclonal antibody

Nov. 21, 2003

ImmunoGen scientists design new prodrugs of CC-1065 analogues

Nov. 21, 2003

Merck presents three series of IGF-1R and IRR inhibitors

Nov. 21, 2003

Novel antiangiogenic agents revealed in recent Abbott patent

Nov. 20, 2003

Roche claims new c-Met kinase inhibitors and their use in cancer therapy

Nov. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...